Article
Itolizumab – a humanized anti-CD6 monoclonal antibody with a better side effects profile…
Clinical, Cosmetic and Investigational Dermatology · 2015 · Menon R, David BG
Key facts
| Title | Itolizumab – a humanized anti-CD6 monoclonal antibody with a better side effects profile for the treatment of psoriasis |
|---|---|
| First author | Menon R, David BG |
| Journal | Clinical, Cosmetic and Investigational Dermatology |
| Published | Apr 17, 2015 |
| DOI | 10.2147/CCID.S47784 |
| Product codes mentioned | FMF, ONB |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1